XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Other Current Assets
 9 Months Ended
Sep. 30, 2024
Other Current Assets [Abstract]  
Other Current Assets
Note 4: Other Current Assets
Other current assets consisted of the following:
September 30, 2024December 31, 2023
Research tax credit9,649 8,857 
Other tax claims5,610 5,236 
Prepaid expenses2,215 2,103 
Other receivables4,844 1,353 
Total22,318 17,548 
Research tax credit
The variance in Research Tax Credit is presented as follows:
Amount in thousands of US dollars
Opening research tax credit receivable as of January 1, 20248,857 
 + Operating income3,640 
- Payment received (2,985)
= - Adjustment and currency translation effect137 
Closing research tax credit receivable as of September 30, 20249,649 
Of which - Non-current portion— 
Of which - Current portion9,649 
Before currency translation effect, the balance in research tax credit as of September 30, 2024, consisted of $8.9 million research tax credit for the previous fiscal year filed with the tax authorities. The $3.0 million research tax credit relating to previous years has already been reimbursed in the third quarter of 2024. The 2023 research tax credit is still awaiting reimbursement in the amount of $6.0 million.The estimated research tax credit for the first nine months of the 2024 fiscal year amounts to $3.6 million.
The other tax claims are primarily related to the VAT as well as the reimbursement of VAT that has been requested. Prepaid expenses are comprised primarily of insurance expenses, as well as legal and scientific consulting fees.
As of September 30, 2024, other receivables include $3.3 million relating to the Services Agreement entered by the Company with Fareva La Vallee, dated March 18, 2024, for the construction of a manufacturing line by Fareva La Vallee for the production and supply of peanut source material for the Company.